Balaxi Pharmaceuticals Ltd

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange that the Board of Directors at its meeting held on February 28, 2024, has considered and approved subdivision of 1 equity shares of 10 each into 5 equity shares of 2 each.